European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Cytogenetics<br />
22 leading to the formation of bcr/abl fusion gene.<br />
Disease relapse still represents the major cause of treatment failure in<br />
patients with CML, following bone marrow transplantation. Thus, the<br />
early detection of minimal residual disease (MRD) has relevant therapeutic<br />
implications.<br />
Sequential cytogenetic analysis was done using standard methods in<br />
bone marrow samples from10 patients with CML. Further dual colour<br />
Fluorescence In Situ Hybridisation (FISH) analysis was done to assess<br />
molecular response using bcr/abl. The chimerism pattern and bcr-abl<br />
status were studied. The results of present study show that bone marrow<br />
transplantation induce both cytogenetic and molecular response<br />
in a significant proportion of CML thereby improving their prognosis<br />
and survival. The importance of using FISH analysis on interphase nuclei<br />
and poor-spread metaphases that cannot be analyzed using conventional<br />
cytogenetics was also highlighted. Thus the present study<br />
stresses on the need for sequential cytogenetic and molecular analysis<br />
in diagnosis and disease management of myeloid leukemias.<br />
P03<strong>16</strong>. Molecular cytogenetic characterization of der (9)<br />
deletions in a case of Philadelphia-negative chronic myeloid<br />
leukemia<br />
A. Bennour 1 , H. Sennana 1 , H. El Omri 2 , S. Mougou 1 , A. Khelif 2 , A. Saad 1 ;<br />
1 Service de cytogenetique et de biologie de la reproduction CHU Farhat Hached,<br />
Sousse, Tunisia, 2 Service d’hématologie CHU Farhat Hached, Sousse,<br />
Tunisia.<br />
About 95% of the patients with chronic myeloid leukemia(CML) have<br />
a Philadelphia chromosome resulting from a reciprocal translocation<br />
between bands 9q34 and 22q11.2 that juxtaposes the 3’ABL<br />
gene to the 5’BCR gene. Recent studies using fluorescence in situ<br />
hybridization(FISH) have reported deletions due to the loss of sequences<br />
proximal to chromosome 9 breakpoint or distal to chromosome<br />
22 breakpoint. In this paper we report on a detailed molecular<br />
cytogenetic characterization carrying der(9) deletions in an apparently<br />
Philadelphia negative CML patient.<br />
FISH experiments were carried out in bone marrow sample from CML<br />
patient at diagnosis. A detailed study using conventional cytogenetic<br />
and FISH analysis was done using ES-FISHprobes, Whole chromosomes<br />
painting and BAC in order to elucidate the mechanism of 9q<br />
deletion.<br />
ES-FISH probes disclosed the BCR/ABL fusion gene on<br />
der(22)chromosome and deletion of signal on der(9) chromosome.<br />
Whole chromosomes painting revealed deletion of ABL/BCR fusion<br />
gene on der(9).<br />
Using FISH with an appropriate set of BAC probes located proximally<br />
to BCR and ABL genes we have characterized the deleted region on<br />
both chromosomes 9 and 22.<br />
Our study shows that the location of the deleted sequences was downstream<br />
of the BCR breakpoint and upstream of ABL gene and that genomic<br />
microdeletions were concomitant with t(9;22) rearrangements.<br />
FISH analysis allowed not only the identification of chromosome rearrangements<br />
that could not otherwise be detected by conventional<br />
banding procedures, but also the recognition of 5’ABL and 3’BCR deletions<br />
which could carry with it a poor prognosis that indicates rapid<br />
disease progression in CML.<br />
P0317. Prenatal diagnosis of an unexpected de novo complex<br />
chromosomal rearrangement.<br />
S. Jaillard 1 , C. Henry 1 , C. Dubourg 2,3 , M. Durou 2 , L. Loeuillet 4 , J. Milon 5 , E.<br />
Bauville 6 , J. Mosser 3 , V. David 2,3 , L. Pasquier 7 , J. Lucas 1 ;<br />
1 Laboratoire de Cytogénétique, CHU Rennes, France, 2 Laboratoire de Génétique<br />
Moléculaire, CHU Rennes, France, 3 UMR 6061 CNRS, Rennes, France,<br />
4 Département d’Anatomie et Cytologie Pathologiques, CHU Rennes, France,<br />
5 Département de Radiologie et Imagerie Médicale, CHU Rennes, France, 6 Département<br />
d’Obstétrique, Gynécologie et Médecine de la Reproduction, CHU<br />
Rennes, France, 7 Service de Génétique Médicale, CHU Rennes, France.<br />
We report a prenatal diagnosis of de novo apparently balanced reciprocal<br />
translocation t(2;10)(q?24;p?15.1) which turned out to be a complex<br />
event after molecular cytogenetic analysis. Fetal conventional<br />
R-banded karyotype was performed on amniocytes at 32 weeks gestation<br />
because of sonographic findings: IUGR, single umbilical artery<br />
and arachnoid cyst of the posterior fossa. To precise the breakpoint on<br />
chromosome 10, molecular cytogenetic analysis by FISH was used<br />
with a 10p14 band-specific probe: unexpectedly, the signal wasn’t<br />
10<br />
localized on the derivative chromosome 2 but on a chromosome 5.<br />
Then, hybridization of whole chromosome painting probes WCP 2, 5<br />
and 10 showed an increasing complexity of the rearrangement leading<br />
to complex derivative chromosomes: der(2) and der(10) were found<br />
to have segments from the three chromosomes as a consequence of<br />
terminal exchanges and insertions. Subtelomeric probes of chromosomes<br />
2, 5 and 10 revealed a terminal deletion of the long arm of chromosome<br />
2 (2qter). Finally, this complex chromosomal rearrangement<br />
seemed to involve 3 chromosomes and 5 breakpoints. The pregnancy<br />
was terminated and the fetopathological examination confirmed prenatal<br />
ultrasound report and showed additional congenital anomalies:<br />
facial dysmorphism, heart defects, corpus callosum and cerebellum<br />
abnormalities. 2qter deletions are associated with variable clinical features<br />
and in our case, the 2qter microdeletion should be responsible<br />
for the phenotype. Array-CGH will be performed in order to precise the<br />
size of the 2qter deletion and to screen for additional cryptic genomic<br />
imbalances near the breakpoints or elsewhere.<br />
P0318. Cytogenetic and Molecular studies in Egyptian patients<br />
with congenital heart defects, A pilot study.<br />
I. M. R. Hussein 1 , N. Helmy 1 , M. El-Rubi 1 , H. A. Hussein 1 , A. El-Gerzawy 1 , A.<br />
Ahmad 1 , A. Fayez 1 , N. Abdel-Rahman 2 ;<br />
1 National Research Centre, Cairo, Egypt, 2 Cairo University, Cairo, Egypt.<br />
Objective: To analyze the frequency of chromosomal anomalies and<br />
molecular defects in Egyptian patients with congenital heart defects<br />
(CHD). Patients and Methods: The study included 34 patients with<br />
congenital heart defects; confirmation of the heart defect was accomplished<br />
by echocardiography and/ or cardiac catheterization.<br />
Chromosomal analysis was done using GTG-banding and FISH techniques.<br />
Mutation detection in transcription factor GATA4 and NKX2.5<br />
was done using PCR/ SSCP and DNA sequencing. Results: Patients<br />
were classified into isolated heart defects (n=21) and CHD associated<br />
with other congenital malformations (n-13). Associated malformations<br />
were: (Down syndrome (2), Aarskog Scott S. (1), velocardiofacial S.<br />
(2 sibs), Russel Silver (1), hand anomaly (2), trisomy 18 (1); and dysmorphic<br />
(4). Chromosomal anomalies were found in 9/30 patients (30<br />
%). They were: Trisomy 21 [47, XY,+21 (1); 46, XX, t(21;21) (1)]; 47,<br />
XX+13 (1); 47,XX,+18 (1); 46, XY, t (14; 18) (q11.2; p11.2) (1); 47, XY +<br />
mar (mat.) (1); 46, XX del 11q 23.3- qter (2 sibs); 46, XX, dup13q33-34<br />
(1). DNA sequencing of NKX2.5 gene in 15 patients with isolated ASD<br />
revealed normal sequence in all cases. Sequencing of GATA4 gene<br />
in 12 patients with Fallot’s tetralogy has shown polymorphism in exon<br />
6 at nucleotide 53423 (A-G) in 2 patients. Conclusion: Chromosomal<br />
analysis of patients with heart defects and other congenital anomalies<br />
has a great impact on diagnosis, prognosis and genetic counseling of<br />
patients. The mutations in isolated defects might be mainly of somatic<br />
origin that could not be observed in peripheral blood lymphocytes.<br />
P03<strong>19</strong>. A case with Prader-Willi phenotype and a de novo<br />
t(2;15)(q31;p11)<br />
T. Cora 1 , H. Acar 1 , A. Kalaycı 1 , E. Atabek 2 ;<br />
1 Dept. of Medical <strong>Genetics</strong>,Meram Medical Faculty, Selcuk Unıversıty, Konya,<br />
Turkey, 2 Dept. of Pediatics, Meram Medical Faculty, Selcuk Unıversıty, Konya,<br />
Turkey.<br />
In recent years, the spectrum of available methods for the characterization<br />
of chromosomal rearrangement has dramatically increased. Thus,<br />
the correlation between phenotype and genotype has been done accurately.<br />
In the present report, we describe the clinical and cytogenetic<br />
findings of a patient with 46,XX,t(2;15)(q31;p11). A 2-year-old girl with a<br />
clinical feature show Prader-Willi phenotype. The patient and her family<br />
were studied by the conventional (GTG, NOR and C-bandings) and<br />
molecular cytogenetic (for PW region) techniques. The results showed<br />
the proband with a balanced de novo karyotype 46,XX,t(2;15)(q31;p11)<br />
by using GTG-banding. Clinical and genetic findings were compared to<br />
the other patients published in the literature.